Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia

Infectious Diseases and Therapy (2021) - Comments
doi: 10.1007/s40121-021-00453-3 pubmed: 33977506 issn: 2193-8229 issn: 2193-6382

Matthew Geriak, Fadi Haddad, Ravina Kullar, Kristina L. Greenwood, MacKenzie Habib, Cole Habib, David Willms, George Sakoulas